Healthcare -
Biotechnology - NASDAQ - US
$ 69.19
-2.05 %
$ 8.55 B
Market Cap
17.31
P/E
HALO - REVENUE
Revenue HALO - Halozyme Therapeutics, Inc.
1.02 B
LAST VALUE
24.02%
2 YEAR CAGR
38.95%
5 YEAR CAGR
29.71%
10 YEAR CAGR